Iodide

Iodide

SCHEMBL3733345

CO[Si](CCCn1cc[n+](C)c1)(OC)OC.[I-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.51
MEN1 O00255 1/20 0.51
APAF1 O14727 1/20 0.51
NPC1 O15118 1/20 0.51
PLA2G1B P04054 1/20 0.51
HSP90AA1 P07900 1/20 0.51
MAPT P10636 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
KMT2A Q03164 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
ATG4B Q9Y4P1 1/20 0.51
FDPS P14324 2/20 0.32
PON1 P27169 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL537081 0.98 SMN1; SMN2 (0.53) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Hydrochloric Acid SCHEMBL503460 0.97 SMN1; SMN2 (0.51) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL16433374 0.86 MEN1 (0.45) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL16724670 0.83 MEN1 (0.42) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL669979 0.82 SMN1; SMN2 (0.54) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Hydrochloric Acid SCHEMBL508922 0.81 MEN1 (0.53) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Iodide SCHEMBL2530883 0.80 SMN1; SMN2 (0.74) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL17706457 0.79 SMN1; SMN2 (0.58) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Iodide SCHEMBL2532625 0.78 SMN1; SMN2 (0.78) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Iodide SCHEMBL2531281 0.78 SMN1; SMN2 (0.78) SMN1; SMN2MEN1APAF1NPC1PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8563459-B2 Fixed-bed hydrosilylation catalyst complexes and related methods Gelest Technology, Inc. (US) 2013-10-22 US disclosed
US-20100280266-A1 Fixed-Bed Hydrosilylation Catalyst Complexes and Related Methods GELEST TECHNOLOGIES INC. (US) 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280266-A1 Fixed-Bed Hydrosilylation Catalyst Complexes and Related Methods CTCF, H1-0, H1-4 SMN1; SMN2 3954/4885MEN1 851/4885APAF1 1887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.